Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845435 | 0.94 | PDE10A (0.32) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL19845423 | 0.94 | PDE10A (0.32) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL19845433 | 0.94 | PDE10A (0.32) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL19845422 | 0.94 | PDE10A (0.32) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL19845416 | 0.94 | PDE10A (0.32) | PDE10AKDM4EALDH1A1PDK2ATM | |
| SCHEMBL19845430 | 0.94 | PDE10A (0.32) | PDE10AKDM4EPDK2ATML3MBTL1 | |
| SCHEMBL18385535 | 0.94 | KDM4E (0.31) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL18385435 | 0.94 | KDM4E (0.31) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL18385453 | 0.94 | KDM4E (0.31) | PDE10AKDM4EALDH1A1HPGDTSHR | |
| SCHEMBL18385444 | 0.94 | KDM4E (0.31) | PDE10AKDM4EALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4261906-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-10-18 | — | — | EP | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | PDE10A 2873/4885KDM4E 2372/4885ALDH1A1 14/4885 |
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | CTNNB1, CYBA, CRY1 | PDE10A 4343/4885KDM4E 2651/4885ALDH1A1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.